Literature DB >> 31894535

Histologic transformation of t(11;18)-positive MALT lymphoma presented with aberrant T-cell marker expression.

Naoki Tamura1, Hirona Maeda2, Momoko Nishikori3, Haruyuki Fujita1, Masakatsu Hishizawa1, Hironori Haga2, Akifumi Takaori-Kondo1.   

Abstract

Mucosa-associated lymphoid tissue (MALT) lymphoma with t(11;18)(q21;q21), resulting in an API2-MALT1 fusion transcript, is reported to rarely transform into aggressive lymphoma. Here, we report the clinical course of a patient who experienced histologic transformation after 20 years' disease history of t(11;18)-positive MALT lymphoma. The patient suddenly developed a large intrapelvic mass and ascites with a rapid increase in lactate dehydrogenase. Cytology of the ascites detected large abnormal cells, and flow cytometric analysis revealed that the cells were positive for cytoplasmic CD3, CD4, and CD38, and partially positive for CD7, but negative for CD19 and CD20. Antigen receptor gene rearrangement analysis and in situ hybridization of the immunoglobulin light chains confirmed that the tumor cells were of B-cell lineage. Chromosomal analysis showed complex karyotypes with intraclonal variation, and in addition to t(11;18), t(8;14) and heterozygous loss of the TP53 were demonstrated. Although histological and phenotypic features were significantly altered from the original MALT lymphoma, the presence of t(11;18) led us to the diagnosis of histologic transformation of MALT lymphoma. Although transformation of t(11;18)-positive MALT lymphoma into aggressive lymphoma is extremely rare, it may occur, probably with additional genetic abnormalities such as cMYC rearrangement and/or the loss of TP53.

Entities:  

Keywords:  API2-MALT1 translocation; Histologic transformation; MALT lymphoma

Mesh:

Substances:

Year:  2020        PMID: 31894535     DOI: 10.1007/s12185-019-02810-y

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.319


  1 in total

1.  Duodenal-type follicular lymphoma more than 10 years after treatment intervention: A retrospective single-center analysis.

Authors:  Makoto Saito; Akio Mori; Shihori Tsukamoto; Takashi Ishio; Emi Yokoyama; Koh Izumiyama; Masanobu Morioka; Takeshi Kondo; Hirokazu Sugino
Journal:  World J Gastrointest Oncol       Date:  2022-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.